Torrent Pharma gets USFDA nod for Alfuzosin hydrochloride

20 Jul 2011 Evaluate

Torrent Pharmaceuticals has received US Food and Drug Administration (USFDA) approval for Alfuzosin hydrochloride extended release tablets.

The tablets used in the treatment of benign prostatic hyperplasia, are generic version of Uroxatral sold by Sanofi. The tablets had annual sales of about $250 million in the US.

Torrent Pharma is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3394.35 -39.90 (-1.16%)
23-Dec-2024 09:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.95
Dr. Reddys Lab 1341.15
Cipla 1468.10
Lupin 2135.85
Zydus Lifesciences 966.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.